Flip Therapeutics develops in vivo immune cell reprogramming therapies for chronic autoimmune and inflammatory diseases.
FLIP THERAPEUTICS has raised $676K in total funding. The most recent round was Seed. The last funding was announced in September 2026.
FLIP THERAPEUTICS's investors include Medicines Discovery Catapult.
FLIP THERAPEUTICS is headquartered in London, United Kingdom.
Flip Therapeutics develops in vivo immune cell reprogramming therapies for chronic autoimmune and inflammatory diseases.
FLIP THERAPEUTICS is at the Seed stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"FLIP THERAPEUTICS — Funding & Investors." VCBacked, September 3, 2026, https://www.vcbacked.co/company/flip-therapeutics. Accessed October 2, 2026.
VCBacked. (2026). FLIP THERAPEUTICS — Funding & Investors. Retrieved October 2, 2026, from https://www.vcbacked.co/company/flip-therapeutics
{{cite web |title=FLIP THERAPEUTICS — Funding & Investors |url=https://www.vcbacked.co/company/flip-therapeutics |website=VCBacked |access-date=October 2, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated